SIMILASAN Affections cutanées glob 15 g

7680508840174 CH-50884 D11AX 20.01.1.
SIMILASAN Affections cutanées glob 15 g
SIMILASAN Affections cutanées glob 15 g
SIMILASAN Affections cutanées glob 15 g
1 / 3
google

Details

Product number
5088401
CPT
-
Packaging group
15
Unit
g
Composition
mercurius solubilis hahnemanni (HAB) D12 2.5 mg, natrium chloratum (HAB) D12 (HAB 5a) 2.5 mg, rhus toxicodendron (HAB) D10 2.5 mg, selenium (HAB) D15 2.5 mg, calcii carbonas, xylitolum 600 mg, ad globulos pro 1 g corresp. 70-90 granula homoeopathica imbuta.

Articles (1)

Similasan Hautausschläge, Globuli
Globuli
15
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/03/2013
Patient information leaflet
Français
08/03/2013
Patient information leaflet
Italien
08/03/2013

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
600.0 MG Substance HBESI

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
50884
Drug name
Similasan Hautausschläge, Globuli
Galenic form
GLO
Authorization status
Z
Dispensation category
D
First authorization
15/07/1991
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Hautausschlägen und Ekzemen

Packaging details

Description (FR)
SIMILASAN Affections cutanées glob 15 g
Description (DE)
SIMILASAN Hautausschläge Glob 15 g
Market launch
15/07/1991
Narcotic (BTM)
No

Other packaging sizes